SOCORRO PHARMA Trademark

Trademark Overview


On Thursday, March 16, 2017, a trademark application was filed for SOCORRO PHARMA with the United States Patent and Trademark Office. The USPTO has given the SOCORRO PHARMA trademark a serial number of 87373560. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 14, 2018. This trademark is owned by Socorro Pharmaceuticals, LLC. The SOCORRO PHARMA trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Antivirals; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of cancer; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for use in dermatology; antifungal preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for ophthalmological use; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of pain and inflammation; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention,...

Wholesale distributorship services featuring generic pharmaceuticals, generic veterinary preparations, and biosimilars; providing advertising, marketing and promotional services for generic pharmaceuticals, generic veterinary preparations, and biosimilars of others

Generic pharmaceutical research and development; testing, inspection and research of generic pharmaceuticals, generic veterinary preparations, and biosimilars
socorro pharma

General Information


Serial Number87373560
Word MarkSOCORRO PHARMA
Filing DateThursday, March 16, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 14, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements


Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesAntivirals; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of cancer; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for use in dermatology; antifungal preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for ophthalmological use; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of pain and inflammation; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, circulatory, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations, substances and biosimilars for use in chemotherapy; pharmaceutical and veterinary preparations, substances and biosimilars for use in urology; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of stress; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of diabetes; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of joint disorders; pharmaceutical and veterinary preparations, substances and biosimilars for controlling insulin levels; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of hypertension, hypercholesteremia, and hyperlipidemia; pharmaceutical preparations, substances and biosimilars for the prevention, treatment and alleviation of angina; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of sexually transmitted diseases; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of sleep disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars, namely, fibrinolytic or thrombolytic agents; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of migraines; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of fungal infections; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of dermatophytosis, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of ophthalmic and ocular disorders, diseases, conditions and ailments; ophthalmic; pharmaceuticals, namely, contact wetting and cleaning lens solutions, contact lens disinfectants, eye drops, solutions, gels, lubricants and ointments used for moisturizing the eye and to treat conditions such as dry eyes, allergies, inflammation, redness and itchy eyes; ophthalmic diagnostic test strips; viscoelastic preparations used in ophthalmic surgery; nasal spray preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of erectile and sexual dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars used in dialysis; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of epilepsy; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergies; pharmaceutical and veterinary preparations, namely, injectable contraceptives; oral and chemical contraceptives; pharmaceutical and veterinary preparations, substances and biosimilars, namely, psychotropics; pharmaceutical preparations, substances and biosimilars for the treatment of gout; antibacterial pharmaceuticals and veterinary preparations, substances and biosimilars; pharmaceuticals and veterinary preparations, substances and biosimilars, namely, antimetics and emetics; anesthetics for surgical and non-surgical use; analgesics; sedatives; tranquilizers; antiparasitics; cough treatment preparations; muscle relaxants; steroids; appetite suppressants and stimulants; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of Lyme disease; hormonal preparations; anthelmintics; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of rheumatoid arthritis and arthritis; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of bacterial infections; veterinary vaccines; diagnostic preparations for veterinary purposes; stem cells for veterinary purposes; enzyme preparations for veterinary purposes; a full line of vitamins, minerals, and nutritional and dietary supplements for human consumption; Albumin dietary supplements; Alginate dietary supplements; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Casein dietary supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement drink mixes; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplemental drinks; Dietary supplements for animals; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for pets; Dietary supplements for treatment of claustrophobia; Dietary supplements for urinary health; Dietary supplements in the nature of weight loss powders; Dietary supplements; dietary supplements featuring grape seed extract, beta carotene, bilberry, black cohosh, cayenne, Garcinia Cambogia extract, garlic oil, coenzyme Q10, collagen, cranberry, echinacea, elderberry extract, garlic, ginkgo biloba, ginseng, goldenseal, green tea, pine extracts, guarana, guggulsterone, gymnema, hawthorn, milk thistle, bark of Pinus pinaster, pygeum, saw palmetto, stevia, St. John's wort, yohimbe, melatonin, notoginseng, aloe vera, garlic oil, fish oil, deep fish oil, namely, deep fish oil for lowering cholesterol and blood pressure, pumpkin seed oil, lecithin, liquid calcium, lysine, squalene, cow colostrums, marine oil, namely, marine oil for preventing or slowing skin from aging, evening primrose oil, sea buckthorn oil, pine oil, safflower oil, bee propolis, placenta, RNA/DNA, namely, RNA/DNA for improving the immune system of human body, spirulina, shark cartilage, natural rose hip oil, soy lecithin, coral calcium, multiamino acid, nucleic acid DNA/RNA, fish protein, natural HCA, noni extract, red dehydroepiandrosterone, DHA-docosahexaenoic acid, EPA eicosapentaenoic acid, ginger extract, multi vitamins, and/or PSP polysaccharide peptide; Enzyme dietary supplements; Enzyme food supplements; Flaxseed dietary supplements; Flaxseed oil dietary supplements; Food supplements, namely, anti-oxidants; Food supplements; Fruit-based meal replacement bars for treating vitamin B12 deficiency that causes fatigue; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Glucose dietary supplements; Ground flaxseed fiber for use as a dietary supplement; Gummy vitamins; Health food supplements; Herbal supplements for sleeping problems; Herbal supplements; Homeopathic supplements; Hormone replacement therapy preparations; Hormones; Human growth hormone; Lecithin dietary supplements; Lecithin for use as a dietary supplement; Linseed dietary supplements; Linseed oil dietary supplements; Liquid herbal supplements; Liquid nutritional supplement; Liquid protein supplements; Liquid vitamin supplements; Liquid vitamin supplements; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral supplements featuring Boron, Calcium, Chromium, Copper, Iodine, Iron, Magnesium, Manganese, Molybdenum, Phosphorus, Potassium, Selenium, Silicon, Vanadium, and/or Zinc; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed hormone preparations; Mixed vitamin preparations; Multi-vitamin preparations; Natural dietary supplements for treatment of claustrophobia; Natural herbal supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Natural supplements for treating candida; Natural supplements for treating depression and anxiety; Natural supplements for treating erectile dysfunction; Non-medicated additives for animal feed for use as nutritional supplements; Nopal cactus juice for use as a nutritional supplement; Nutraceuticals for use as a dietary supplement; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritional supplements, namely, carbohydrates in powdered form; Nutritional supplements, namely, probiotic compositions; Nutritional supplements; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pollen dietary supplements; Powdered fruit-flavored dietary supplement drink mix; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix; Prenatal vitamins; Probiotic supplements; Propolis dietary supplements; Protein dietary supplements; Protein supplement shakes for weight gain purposes; Protein supplement shakes; Protein supplements for animals; Protein supplements; Royal jelly dietary supplements; Soy protein dietary supplements; Topical preparations, namely, testosterone creams for enhancing sexual arousal; Vegan liquid protein supplements; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Vitamin A preparations; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin B preparations; Vitamin C preparations; Vitamin D preparations; Vitamin drops; Vitamin enriched bread for therapeutic purposes; Vitamin enriched chewing gum for medical purposes; Vitamin enriched sparkling water for medical purposes; Vitamin enriched water for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin oils for human consumption; Vitamin preparations; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin supplements; Vitamin tablets; Vitamins and dietary food supplements for animals; Vitamins and vitamin preparations; Vitamins and vitamin supplements, namely, Thiamin, Riboflavin, Niacin, Pyridoxine, Cyanocobalamin, Folacin, Biotin, Vitamin A, Vitamin B-complex, Vitamin C, Vitamin D, Vitamin E, Vitamin K, and multi-vitamins with iron supplements; Vitamins for pets; Vitamins; Weight management supplements; Wheat for use as a dietary supplement; Wheat germ dietary supplements; Wheatgrass for use as a dietary supplement; Whey protein supplements; Yeast dietary supplements; Zinc supplement lozenges
Goods and ServicesWholesale distributorship services featuring generic pharmaceuticals, generic veterinary preparations, and biosimilars; providing advertising, marketing and promotional services for generic pharmaceuticals, generic veterinary preparations, and biosimilars of others
Goods and ServicesGeneric pharmaceutical research and development; testing, inspection and research of generic pharmaceuticals, generic veterinary preparations, and biosimilars
Translation of Words in MarkThe English Translation of the word "SOCORRO" in the mark is "AID".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2017
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSocorro Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78701

Party NameSocorro Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAustin, TX 78701

Trademark Events


Event DateEvent Description
Monday, May 14, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 14, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 12, 2017EXAMINER'S AMENDMENT ENTERED
Monday, June 12, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 12, 2017EXAMINERS AMENDMENT E-MAILED
Monday, June 12, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, June 9, 2017ASSIGNED TO EXAMINER
Wednesday, March 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 20, 2017NEW APPLICATION ENTERED IN TRAM